---
figid: PMC6600524__ijms-20-02802-g001
figtitle: Schematic representation of androgen deprivation therapy (ADT) or androgen
  receptor (AR) antagonist in mediating therapeutic resistance and neuroendocrine
  (NE) differentiation of prostate cancer (PCa)
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC6600524
filename: ijms-20-02802-g001.jpg
figlink: /pmc/articles/PMC6600524/figure/ijms-20-02802-f001/
number: F1
caption: Schematic representation of androgen deprivation therapy (ADT) or androgen
  receptor (AR) antagonist in mediating therapeutic resistance and neuroendocrine
  (NE) differentiation of prostate cancer (PCa). Inactivates of the AR–SAM pointed
  domain-containing ETS transcriptional factor (SPDEF) signaling pathway via AR antagonist
  or by ADT induce the expression of ZBTB46, TGFBI, and CCL2 (Left). ZBTB46 acts as
  a transcriptional inducer for LIF, PTGS1, and Snail, which further enhance tumor
  progression, metastasis, therapeutic resistance, and castration-resistant PCa (CRPC)-NE
  differentiation of PCa (Right).
papertitle: 'ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets
  in Castration-Resistant Prostate Cancer.'
reftext: AbdulFattah Salah Fararjeh, et al. Int J Mol Sci. 2019 Jun;20(11):2802.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9299335
figid_alias: PMC6600524__F1
figtype: Figure
redirect_from: /figures/PMC6600524__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6600524__ijms-20-02802-g001.html
  '@type': Dataset
  description: Schematic representation of androgen deprivation therapy (ADT) or androgen
    receptor (AR) antagonist in mediating therapeutic resistance and neuroendocrine
    (NE) differentiation of prostate cancer (PCa). Inactivates of the AR–SAM pointed
    domain-containing ETS transcriptional factor (SPDEF) signaling pathway via AR
    antagonist or by ADT induce the expression of ZBTB46, TGFBI, and CCL2 (Left).
    ZBTB46 acts as a transcriptional inducer for LIF, PTGS1, and Snail, which further
    enhance tumor progression, metastasis, therapeutic resistance, and castration-resistant
    PCa (CRPC)-NE differentiation of PCa (Right).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ar
  - Ccl2
  - Slc22a3
  - Spdef
  - Zbtb46
  - Tgfbi
  - Ccdc80
  - Dclk2
  - Ptgs1
  - Lif
  - Snai1
  - AR
  - CCL2
  - ITK
  - SLC22A3
  - SPDEF
  - ZBTB46
  - TGFBI
  - ADGRL2
  - CCDC80
  - DCLK2
  - ERVW-5
  - PTGS1
  - LIF
  - SNAI1
  - Itk
  - Lifr
  - ar
  - ccl38a.5
  - spdef
  - zbtb46
  - tgfbi
  - polr2d
  - ccdc80
  - ptgs1
  - m17
  - snai1a
  - Testosterone
  - cancer
---
